Literature DB >> 26900291

Role of Tim-3 in hepatitis B virus infection: An overview.

Yuan Liu1, Li-Fen Gao1, Xiao-Hong Liang1, Chun-Hong Ma1.   

Abstract

Hepatitis B virus (HBV) infection has received increasing public attention. HBV is the prototypical member of hepadnaviruses, which naturally infect only humans and great apes and induce the acute and persistent chronic infection of hepatocytes. A large body of evidence has demonstrated that dysfunction of the host anti-viral immune response is responsible for persistent HBV replication, unresolved inflammation and disease progression. Many regulatory factors are involved in immune dysfunction. Among these, T cell immunoglobulin domain and mucin domain-3 (Tim-3), one of the immune checkpoint proteins, has attracted increasing attention due to its critical role in regulating both adaptive and innate immune cells. In chronic HBV infection, Tim-3 expression is elevated in many types of immune cells, such as T helper cells, cytotoxic T lymphocytes, dendritic cells, macrophages and natural killer cells. Tim-3 over-expression is often accompanied by impaired function of the above-mentioned immunocytes, and Tim-3 inhibition can at least partially rescue impaired immune function and thus promote viral clearance. A better understanding of the regulatory role of Tim-3 in host immunity during HBV infection will shed new light on the mechanisms of HBV-related liver disease and suggest new therapeutic methods for intervention.

Entities:  

Keywords:  Hepatitis B virus; Immunity; Inflammation; Liver disease; Tim-3

Mesh:

Substances:

Year:  2016        PMID: 26900291      PMCID: PMC4735003          DOI: 10.3748/wjg.v22.i7.2294

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  74 in total

1.  CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Authors:  Yu-Hwa Huang; Chen Zhu; Yasuyuki Kondo; Ana C Anderson; Amit Gandhi; Andrew Russell; Stephanie K Dougan; Britt-Sabina Petersen; Espen Melum; Thomas Pertel; Kiera L Clayton; Monika Raab; Qiang Chen; Nicole Beauchemin; Paul J Yazaki; Michal Pyzik; Mario A Ostrowski; Jonathan N Glickman; Christopher E Rudd; Hidde L Ploegh; Andre Franke; Gregory A Petsko; Vijay K Kuchroo; Richard S Blumberg
Journal:  Nature       Date:  2014-10-26       Impact factor: 49.962

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages.

Authors:  Wenjiang Yan; Xiao Liu; Hongxin Ma; Hualin Zhang; Xiaojia Song; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Gut       Date:  2015-01-21       Impact factor: 23.059

4.  Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.

Authors:  Zhu Li; Na Li; Qianqian Zhu; Guoyu Zhang; Qunying Han; Pingping Zhang; Meng Xun; Yawen Wang; Xiaoyan Zeng; Cuiling Yang; Zhengwen Liu
Journal:  Infect Genet Evol       Date:  2013-01-02       Impact factor: 3.342

5.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.

Authors:  Wing-Kin Sung; Hancheng Zheng; Shuyu Li; Ronghua Chen; Xiao Liu; Yingrui Li; Nikki P Lee; Wah H Lee; Pramila N Ariyaratne; Chandana Tennakoon; Fabianus H Mulawadi; Kwong F Wong; Angela M Liu; Ronnie T Poon; Sheung Tat Fan; Kwong L Chan; Zhuolin Gong; Yujie Hu; Zhao Lin; Guan Wang; Qinghui Zhang; Thomas D Barber; Wen-Chi Chou; Amit Aggarwal; Ke Hao; Wei Zhou; Chunsheng Zhang; James Hardwick; Carolyn Buser; Jiangchun Xu; Zhengyan Kan; Hongyue Dai; Mao Mao; Christoph Reinhard; Jun Wang; John M Luk
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330

6.  Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

Authors:  Jian Ge; Kai Wang; Qing-Hua Meng; Zhao-Xia Qi; Fan-Li Meng; Yu-Chen Fan
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

7.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function.

Authors:  Andrea M Woltman; Marjoleine L Op den Brouw; Paula J Biesta; Cui C Shi; Harry L A Janssen
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

9.  Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.

Authors:  Ying Zhang; Cheng J Ma; Jia M Wang; Xiao J Ji; Xiao Y Wu; Zhan S Jia; Jonathan P Moorman; Zhi Q Yao
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

Review 10.  Innate immune responses in hepatitis B virus (HBV) infection.

Authors:  Aurelia Busca; Ashok Kumar
Journal:  Virol J       Date:  2014-02-07       Impact factor: 4.099

View more
  12 in total

1.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

2.  Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway.

Authors:  Salvatore Chirumbolo
Journal:  Inflamm Res       Date:  2017-11-13       Impact factor: 4.575

Review 3.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.

Authors:  Krupa R Mysore; Rafik M Ghobrial; Sunil Kannanganat; Laurie J Minze; Edward A Graviss; Duc T Nguyen; Katherine K Perez; Xian C Li
Journal:  Am J Transplant       Date:  2017-11-20       Impact factor: 8.086

5.  Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.

Authors:  Ping Zhang; Yan Wang; Xue-Rong Liu; Shi-Ru Hong; Jian Yao
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

6.  Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection.

Authors:  Soheil Tavakolpour; Seyed Moayed Alavian; Shahnaz Sali
Journal:  Hepat Mon       Date:  2016-05-25       Impact factor: 0.660

7.  Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.

Authors:  Zhu Li; Na Li; Fang Li; Zhihua Zhou; Jiao Sang; Yanping Chen; Qunying Han; Yi Lv; Zhengwen Liu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 8.  Immune regulation by Tim-3.

Authors:  Hridesh Banerjee; Lawrence P Kane
Journal:  F1000Res       Date:  2018-03-14

Review 9.  Immune checkpoint receptors: homeostatic regulators of immunity.

Authors:  Antonio Riva; Shilpa Chokshi
Journal:  Hepatol Int       Date:  2018-05-08       Impact factor: 6.047

Review 10.  The Role of PD-1 in Acute and Chronic Infection.

Authors:  Jil M Jubel; Zachary R Barbati; Christof Burger; Dieter C Wirtz; Frank A Schildberg
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.